Vivos Therapeutics Correlations
| VVOS Stock | USD 5.82 0.09 1.57% |
The current 90-days correlation between Vivos Therapeutics and Rapid Micro Biosystems is -0.02 (i.e., Good diversification). The correlation of Vivos Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Vivos Therapeutics Correlation With Market
Average diversification
The correlation between Vivos Therapeutics and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Vivos Stock
| 0.67 | DOCS | Doximity | PairCorr |
| 0.7 | FIGS | Figs Inc | PairCorr |
| 0.76 | MDAI | Spectral AI | PairCorr |
| 0.77 | MGRM | Monogram Orthopaedics Trending | PairCorr |
Moving against Vivos Stock
| 0.44 | CI | Cigna Corp | PairCorr |
| 0.6 | EHAB | Enhabit | PairCorr |
| 0.5 | ELMD | Electromed | PairCorr |
| 0.48 | MSPRZ | MSP Recovery Symbol Change | PairCorr |
| 0.41 | EKSO | Ekso Bionics Holdings | PairCorr |
| 0.31 | EDAP | EDAP TMS SA | PairCorr |
| 0.82 | MLSS | Milestone Scientific | PairCorr |
| 0.73 | MNDR | Mobile health Network | PairCorr |
| 0.6 | NXLIW | Nexalin Technology | PairCorr |
| 0.56 | MGRX | Mangoceuticals, Common | PairCorr |
| 0.53 | MODD | Modular Medical | PairCorr |
| 0.36 | NXGLW | NexGel Warrant | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Vivos Stock performing well and Vivos Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vivos Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BBLG | 4.91 | (0.43) | 0.00 | (0.55) | 0.00 | 10.10 | 47.51 | |||
| TIVC | 4.80 | (0.20) | 0.06 | 0.10 | 5.70 | 7.36 | 132.46 | |||
| BJDX | 4.27 | (0.66) | 0.00 | (0.15) | 0.00 | 8.38 | 59.58 | |||
| RPID | 3.45 | 0.66 | 0.16 | 1.07 | 3.36 | 8.12 | 35.51 | |||
| NAOV | 8.32 | (2.00) | 0.00 | (1.20) | 0.00 | 34.48 | 98.23 | |||
| TLIS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NUWE | 8.67 | (0.22) | (0.01) | 0.00 | 11.26 | 11.11 | 132.35 | |||
| HSCS | 4.97 | 0.18 | 0.05 | 0.21 | 6.45 | 8.17 | 58.52 |
Vivos Therapeutics Corporate Management
| RaeAnn Byrnes | CoFounder Services | Profile | |
| Kirk Huntsman | Chairman CoFounder | Profile | |
| Julie Gannon | Chief Relations | Profile | |
| Nicholas DeGennaro | Senior Division | Profile | |
| John Ballard | Senior Technology | Profile | |
| Ruth Hembree | Senior Services | Profile | |
| Todd Huntsman | CoFounder Technology | Profile |